New #Stocks
to Watch at Investor Ideas in #Biotech (NasdaqGS: $TLIS) (NasdaqGS: $BVS), #Tech
(NasdaqGS: $BMBL), #Mining
(CSE: $ALI.C) and #RealEstate (NYSE: $LDI)
Point
Roberts WA, Delta BC, April 16, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news
source and leading retail investor and trader resource, announces its weekly
roundup of stocks to watch in Biotech, Tech, Mining and Real Estate. Today’s
stocks have been added to our lists of free stock directories in each sector.
Read this in full at https://www.investorideas.com/news/2021/main/04161Stocks.asp
The newest biotech companies are involved in life
sciences including for COVID19, healing therapies and home healthcare and
biopharma companies focused on cell therapies and hearing & balance
treatments.
The latest tech company is involved in dating apps,
while the newest mining company operated in Canada.
Finally, the newest real estate company is involved
in the mortgage/re-financing industry.
New Stocks added to Biotech Stocks Directory:
Apria,
Inc. (NasdaqGS:APR) is
a leading provider of integrated home healthcare equipment and related services
in the United States. The Company offers a comprehensive range of products and
services for in-home care and delivery across three core service lines: (1)
home respiratory therapy (including home oxygen and non-invasive ventilation
(“NIV”) services); (2) obstructive sleep apnea (“OSA”) treatment (including
continuous positive airway pressure (“CPAP”) and bi-level positive airway
pressure devices, and patient support services); and (3) negative pressure
wound therapy (“NPWT”). Additionally, the Company supplies a wide range of home
medical equipment and other products and services to help improve the quality
of life for patients with home care needs. Our revenues are generated through
fee-for-service and capitation arrangements with payors for equipment,
supplies, services and other items we rent or sell to patients. Through our
offerings, we also provide patients with a variety of clinical and
administrative support services and related products and supplies, most of
which are prescribed by a physician as part of a care plan. We are focused on
being the industry’s highest-quality provider of home healthcare equipment and
related services, while maintaining our commitment to being a low-cost
operator. The Company serves over 2 million patients annually and offers a
compelling value proposition to patients, providers and payors by allowing
patients to receive necessary care and services in the comfort of their own
home, while, at the same time, reducing the costs of treatment.
Decibel Therapeutics, Inc. (NasdaqGS:DBTX) is a clinical-stage biotechnology company dedicated to discovering and
developing transformative treatments to restore and improve hearing and
balance, one of the largest areas of unmet need in medicine. Decibel has built
a proprietary platform that integrates single-cell genomics and bioinformatic
analyses, precision gene therapy technologies and expertise in inner ear
biology. Decibel is leveraging its platform to advance gene therapies designed
to selectively replace genes for the treatment of congenital, monogenic hearing
loss and to regenerate inner ear hair cells for the treatment of acquired
hearing and balance disorders. Decibel’s pipeline, including its lead gene
therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is
designed to deliver on our vision of a world in which the privileges of hearing
and balance are available to all.
Longeveron Inc. (NasdaqCM:LGVN) is a clinical stage biotechnology company developing cellular therapies
for specific aging-related and life-threatening conditions. The Company’s lead
investigational product is the LOMECEL-B™ cell-based therapy product
(“Lomecel-B”), which is derived from culture-expanded medicinal signaling cells
(MSCs) that are sourced from bone marrow of young, healthy adult donors.
Longeveron believes that by using the same cells that promote tissue repair,
organ maintenance, and immune system function, it can develop safe and
effective therapies for some of the most difficult disorders associated with
the aging process and other medical disorders. Longeveron is currently
sponsoring Phase 1 and 2 clinical trials in the following indications: Aging
Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress
Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). The Company’s
mission is to advance Lomecel-B and other cell-based product candidates into
pivotal Phase 3 trials, with the goal of achieving regulatory approvals,
subsequent commercialization and broad use by the healthcare community.
NexImmune,
Inc (NasdaqGS:NEXI) is
a clinical-stage biotechnology company developing a novel approach to
immunotherapy designed to employ the body’s own T cells to generate a specific,
potent, and durable immune response. The backbone of NexImmune’s approach is a
proprietary Artificial Immune Modulation (AIM™) nanoparticle technology
platform. The AIM technology enables NexImmune to construct nanoparticles that
function as synthetic dendritic cells capable of directing a specific T
cell-mediated immune response. AIM constructed nanoparticles employ natural
biology to engage, activate and expand endogenous T cells in ways that combine
anti-tumor attributes of antigen-specific precision, potency and long-term
persistence with reduced potential for off-target toxicities. NexImmune’s two
lead programs, NEXI-001 and NEXI-002, are in Phase 1/2 clinical trials for the
treatment of relapsed AML after allogeneic stem cell transplantation and
multiple myeloma refractory to at least 3 prior lines of therapy, respectively.
NexImmune is also developing new AIM nanoparticle constructs and modalities for
potential clinical evaluation in oncology and in disease areas outside of
oncology, including autoimmune disorders and infectious disease.
Bioventus Inc. (NasdaqGS:BVS) delivers
clinically proven, cost-effective products that help people heal quickly and
safely. Its mission is to make a difference by helping patients resume and
enjoy active lives. The Innovations for Active Healing from Bioventus include offerings
for osteoarthritis, surgical and non-surgical bone healing. Built on a
commitment to high quality standards, evidence-based medicine and strong
ethical behavior, Bioventus is a trusted partner for physicians worldwide.
Talis Biomedical Corp (NasdaqGS:TLIS) is
dedicated to transforming diagnostic testing by developing and commercializing
innovative products that are designed to enable accurate, low cost and rapid
molecular testing for infectious diseases at the point-of-care, beginning with
COVID-19. The company is developing Talis One, a compact, sample-to-answer,
cloud-enabled, molecular diagnostic platform. Talis is headquartered in Menlo
Park, California
New Stocks added to Tech Stocks Directory:
Bumble
Inc. (NasdaqGS:BMBL) is
the parent company of Badoo and Bumble, two of the world’s highest-grossing
dating apps with millions of users worldwide. The Bumble platform enables
people to connect and build equitable and healthy relationships. Founded by CEO
Whitney Wolfe Herd in 2014, the Bumble app is one of the first dating apps
built with women at the center, and the Badoo app, which was founded in 2006,
is one of the pioneers of web and mobile dating products. Bumble currently
employs over 700 people in offices in Austin, Barcelona, London, and Moscow.
New Stocks added to Mining Stocks Directory:
Ameriwest Lithium Inc. (CSE:ALI) Formerly Oakley Ventures Inc - is a junior
Canadian-based mining company with a focus on identifying and evaluating
mineral resource projects for further exploration and future development, if
warranted. The Company is currently
focused on completing an exploration program on its Koster Dam property located
in the Clinton Mining Division of British Columbia,
New Stocks added to Real Estate Stocks Directory:
loanDepot, Inc. (NYSE:LDI) is a contemporary financial services company dedicated to
delivering a best-in-class experience to its mortgage purchase and refinance
customers. Founded in 2010, loanDepot offers a diversified network of
direct-to-consumer, in-market and partner business channels, uniquely
positioning it to serve a wide range of customers. Headquartered in Southern
California, the Company has funded more than $300 billion since its founding
and currently ranks as the second largest retail nonbank lender and one of the
leading retail mortgage lenders in the United States. Committed to serving the
communities in which its team members live and work, loanDepot has donated
millions of dollars to support a variety of local, regional and national
philanthropic efforts, most recently giving more than $2.5 million to help with
COVID-related efforts for first responders, healthcare workers, individuals and
families nationwide. The Company also is a founding sponsor of War Heroes on
Water, which supports ongoing therapeutic healing services for combat-wounded
veterans nationwide.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a
recognized news source publishing third party news and press releases, research
and our own original financial content. We were one of the first retail
investor sites to cover renewable energy and cleantech stocks at
investorideas.com and our domain Renewableenergystocks.com. We were also one of
the most well- known and cited defense stock sites, featuring our domain
Homelanddefensestocks.com at its peak.
We follow the money for
investors as sector sentiment shifts and technology disrupts. Our mission is to
provide investor ideas with breaking news, resources, industry articles and
interviews with leading experts.
Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking
at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy and more. Investor Idea's original branded content includes the
following podcasts and columns: Crypto
Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the
sectors we cover use our news and content services to
tell their story to interested investors. Paid for content is
disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media,
podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club
https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
No comments:
Post a Comment